With over 15 years of clinical practice and pharmacometric experience, we know how to analyse trial data from the pharmaceutical and biotechnology industry.
Model Answers will be attending WCoP in Seoul, Korea, September 2012. Please contact Bruce Green to see how Model Answers can help you.
Welcome
With over 15 years of clinical practice and pharmacometric experience, we know how to analyse trial data from the pharmaceutical and biotechnology industry. Model Answers Pty Ltd uses innovative model based methodologies to help the industry make informative decisions during the entire drug development program and specialises in:
- Population Pharmacokinetic Analyses
- Population Pharmacokinetic – Pharmacodynamic Analyses
- Disease Progression Modelling
- Optimal Design of Clinical Trial
- Stochastic Simulation Studies
Latest News Read More »
-
Bruce Green Appointed as Adjunct Associate Professor at UQ School of Medicine
Bruce Green has been appointed as an Adjunct Associate Professor at the School of Medicine, University of Queensland – Mater Clinical School. (more…)
Posted on November 30, 2011 -
Introductory Population Data Analysis Courses During Sept / Oct 2011
Bruce Green and Glynn Morrish will be in Europe during Sept / Oct 2011 teaching an Introductory Course in Pharmacometrics. (more…)
Posted on August 25, 2011 -
Bruce Green joins the Editorial Board of Clinical Pharmacokinetics
Bruce Green has joined the editorial board of the journal Clinical Pharmacokinetics, for further information about the journal please visit the website.
Posted on October 17, 2010 -
Introductory Course in Pharmacometrics – Kings College, London, December 2010
Bruce Green and Glynn Morrish will be teaching an Introductory Course in Pharmacometrics at Kings College, London from 8th – 10th December 2010. (more…)
Posted on June 28, 2010
OUR CLIENTS
- ~ Imaginot Pty Ltd
Imaginot’s relationship with Bruce Green extends back to 2004 when he undertook a consulting assignment to review the results of a proof of concept pharmacokinetic (PK) study and recommend what further analyses could be undertaken to translate the PK data into pharmacodynamic (PD) outcomes. That project was the basis for an ongoing collaboration with Bruce resulting in the results of the subsequent PK-PD modelling being submitted for publication.
(more…) - Read more testimonials »